Inmode Stock

Inmode EBITDA Margin

The EBITDA Margin of Inmode (INMD) as of Aug 10, 2026 is 23.05 %. In the previous year, EBITDA Margin was 28.50 % — a change of -19.14% (lower).

EBITDA Margin

23.05 %

YoY

-19.14%

Last updated:

EBITDA Margin of Inmode is 2026 23.05 % . EBITDA Margin of Inmode was 2025 28.50 % . It decreases by -19.14% lower compared to the previous year.
Access this data via the Eulerpool API

Inmode Stock analysis

What does Inmode do? Inmode Ltd is a leading company in the field of aesthetic medicine, offering innovative technologies used by doctors and beauty clinics around the world to help patients improve their beauty and well-being. The company was founded in 2008 and is headquartered in Yokneam, Israel, with offices in North America, Europe, and Asia. Inmode is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inmode stock

EBITDA Margin of Inmode is 23.05 % in 2026.

EBITDA Margin of Inmode changed from 28.50 % to 23.05 %, representing a -19.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Inmode since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Inmode with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

Margins — Inmode

All Key Metrics — Inmode